Balyasny Asset Management »

Neumora Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $112k 58k 1.95
2024-06-30 $3.7M 380k 9.83
2024-03-31 $9.5M 688k 13.75

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
Siren
Perceptive Advisors
Vanguard Group
MIC Capital Management UK
Vanguard Capital Management
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Millennium Management
ICONIQ Capital
Lunate Capital
BlackRock
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies

View all funds holding Neumora Therapeutics